ERBB2 and gastric adenocarcinoma: Acknowledging the contradictory findings concerning the prognostic impact of HER-2, our investigation focused on evaluating the influence of different HER-2 categories (negative, low, and positive) on clinical and pathological characteristics, metastatic spread, and overall survival in patients with advanced gastric adenocarcinoma.